Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of Cardiac Science Corporation (?Cardiac Science? or the ?Company?) (NASDAQ:CSCX) related to the Company's agreement to be acquired by Opto Circuits (India) Ltd. (?Opto Circuits?). The proposed transaction is valued at approximately $55 million.

Under the terms of the definitive merger agreement entered into by the parties, Cardiac Science shareholders will receive $2.30 in cash for each share they own of the Company's common stock. The transaction is structured as an all-cash tender offer by a wholly owned subsidiary of Opto Circuits followed by a second-step merger. The transaction is expected to be completed by fourth quarter 2010. If the transaction is completed, Cardiac Science will operate as a wholly owned subsidiary of Opto Circuits. The investigation concerns possible breaches of fiduciary duty and other violations of law related to approval of the proposed transaction by the Cardiac Science board of directors.

If you are a shareholder of Cardiac Science, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at 215-638-4847, Toll Free at 888-638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at http://www.howardsmithlaw.com.

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com